It is not FDA approved yet, but a regulatory submission is expected in early 2026, which puts a potential U.S
Company executives also said that the higher-strength version is allowing it to "level the playing field from an efficacy standpoint." Muscle loss data In another secondary finding revealed at ECO, the trial investigators determined that the majority of the weight loss achieved with Wegovy around 84% - resulted from the loss of fat, suggesting the impact of the treatment on muscle mass was minimal
Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice
Despite claims by the indoor tanning industry, there is little evidence it's any safer than sunlight
Understanding how these medications work is the first step toward making an informed decision
Holland, MD, MS, lead author, total joint arthroplasty surgeon at Campbell Clinic Orthopaedics and a faculty instructor at the University of Tennessee Health Science Center in Memphis